Charles Flexner
MD
Johns Hopkins University School of Medicine, United States
2nd International Workshop On Long Acting Anti-Infectives (LAAI) 2026
What's New
- The exact date and location of LAAI 2026 is being confirmed. We will share the updates here shortly!
About this Program
The International Workshop On Long Acting Anti-Infectives (LAAI) is a crucial platform for advancing the development, implementation, and scale-up of long-acting and extended-release (LA/ER) anti-infective therapies. This 1st edition of the workshop will explore the transformative potential of LA/ER drug delivery in infectious disease management, with a focus on recent breakthroughs in HIV prevention and treatment.
Attendees will discuss the clinical application of these therapies in populations with historically low adherence, including pediatric patients, pregnant and breastfeeding women, and individuals experiencing homelessness.
By sharing knowledge on trial design, safety, efficacy, and implementation strategies, this 2-day hybrid workshop will contribute to the global effort to improve health outcomes, extending the benefits of these therapies beyond HIV to other infectious diseases like tuberculosis, malaria, and viral hepatitis.
Organizing Committee
Daniel Kuritzkes
MD
Brigham and Women's Hospital / Harvard Medical School, United States
Kimberly Scarsi
PharmD, MS, FCCP
University of Nebraska Medical Center (UNMC), United States
Jonathan Schapiro
MD
National Hemophilia Center, Sheba Medical Center, Israel
Laura Waters
MD, FRCP
Central & North West London NHS Foundation Trust, United Kingdom